Maxymune Therapeutics, Inc.

CIK 2058052 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Maxymune Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Jun 3, 2026D/A0002058052-26-000004
Feb 28, 2025D0002058052-25-000003